It is a pharma private limited company based in Assam-781354, Assam, India, established in 2006.
2006 | Assam-781354, Assam, India | ActiveSepty Pharmaceuticals Private Limited, a active private limited company, was established on 12 May 2006 in Assam-781354, Assam, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232AS2006PTC008149. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹2.17 Cr.
It upholds a compliant status. Its leadership includes Anju Kumari (Director), Suresh Chand Saini (Director). Past directors included Hiranya Kumar Das, Ronit Phukan, Gauranga Kakati. It holds ₹29.99 Cr open charges and ₹11.03 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Kekanikuchi Septy,Dipteswari Road, P.O. Moranjana, P.S. Rangiya,, Assam-781354, Assam.
U24232AS2006PTC008149
008149
12 May 2006
₹3.50 Cr
₹2.17 Cr
Roc Guwahati
Unlisted
Active
Explore comprehensive insights into Septy Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anju Kumari | Director | 15 Mar 2022 | Current |
| Suresh Chand Saini | Director | 07 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 04 Jun 2013 | Past |
| Pramod Abcsdd | Director | 14 Mar 2022 | Past |
| Pramod Abcsdd | Director | 31 Jan 2015 | Past |
| Pramod Abcsdd | Director | 31 Jan 2015 | Past |
| Pramod Abcsdd | Director | 14 Mar 2022 | Past |
| Pramod Abcsdd | Director | 14 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Septy Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Septy Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹299,887,000.00
₹110,258,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jul 2022 | Hdfc Bank Limited | ₹29.99 Cr | Open |
| 10 Jun 2011 | Assam Gramin Vikash Bank | ₹6.08 Cr | Satisfied |
| 03 Mar 2009 | Allahabad Bank | ₹4.95 Cr | Satisfied |
Explore comprehensive loan charge details -
Septy Pharmaceuticals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Septy Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Septy Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Septy Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 29.99 Cr registered on 04 Jul 2022 with Charge ID 100684083 was modified on 24 Jun 2024. was recorded as a recent event.
Septy Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 29.99 Cr with Charge ID 100684083 was registered on 04 Jul 2022. was recorded as a recent event.
The activity A charge registered on 10 Jun 2011 via Charge ID 10294437 with Assam Gramin Vikash Bank was fully satisfied on 16 Jun 2022. was completed.
Anju Kumari was appointed as a Director was appointed as a Director on 15 Mar 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
The CIN of Septy Pharmaceuticals Private Limited is U24232AS2006PTC008149.
Septy Pharmaceuticals Private Limited is headquartered at Kekanikuchi Septy,Dipteswari Road, P.O. Moranjana, P.S. Rangiya,, Assam-781354, Assam.
Septy Pharmaceuticals Private Limited was incorporated on 12 May 2006.
The current directors of Septy Pharmaceuticals Private Limited are
The primary industry of Septy Pharmaceuticals Private Limited is Manufacturing.
Septy Pharmaceuticals Private Limited is unlisted.
The authorized capital of Septy Pharmaceuticals Private Limited is ₹3.50 Cr, and the paid-up capital is ₹2.17 Cr.
The compliance status of Septy Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX